Cargando…
Listeria monocytogenes: a promising vector for tumor immunotherapy
Cancer receives enduring international attention due to its extremely high morbidity and mortality. Immunotherapy, which is generally expected to overcome the limits of traditional treatments, serves as a promising direction for patients with recurrent or metastatic malignancies. Bacteria-based vect...
Autores principales: | Ding, Yi-Dan, Shu, Lin-Zhen, He, Rui-Shan, Chen, Kai-Yun, Deng, Yan-Juan, Zhou, Zhi-Bin, Xiong, Ying, Deng, Huan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587691/ https://www.ncbi.nlm.nih.gov/pubmed/37868979 http://dx.doi.org/10.3389/fimmu.2023.1278011 |
Ejemplares similares
-
Listeria monocytogenes as a Vector for Cancer Immunotherapy
por: Leitão, Jorge H.
Publicado: (2020) -
Listeria monocytogenes as a Vector for Cancer Immunotherapy: Current Understanding and Progress
por: Flickinger, John C., et al.
Publicado: (2018) -
Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy
por: Wood, Laurence M., et al.
Publicado: (2014) -
Host Lipid Rafts as the Gates for Listeria monocytogenes Infection: A Mini-Review
por: Tsai, Yu-Huan, et al.
Publicado: (2020) -
Anti-inflammatory, antioxidant and anti-virulence roles of atractylodin in attenuating Listeria monocytogenes infection
por: Xu, Lei, et al.
Publicado: (2022)